164 related articles for article (PubMed ID: 34469564)
1. Global Rotavirus and Pneumococcal Conjugate Vaccine Introductions and the Association With Country Disease Surveillance, 2006-2018.
Peck ME; Hampton LM; Antoni S; Ogbuanu I; Serhan F; Nakamura T; Walldorf JA; Cohen AL
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S184-S193. PubMed ID: 34469564
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme.
Madhi SA; Bamford L; Ngcobo N
S Afr Med J; 2014 Mar; 104(3 Suppl 1):228-34. PubMed ID: 24893498
[TBL] [Abstract][Full Text] [Related]
3. Predictors of uptake of newly introduced vaccines in Malawi - monovalent human rotavirus and pneumococcal conjugate vaccines: Evidence from the 2015-16 Malawi demographic and health survey.
Ntenda PAM; Mwenyenkulu ET; Putthanachote N; Nkoka O; Mhone TG; Motsa MPS; Tizifa T
J Trop Pediatr; 2019 Jun; 65(3):287-296. PubMed ID: 30085260
[TBL] [Abstract][Full Text] [Related]
4. Using pneumococcal and rotavirus surveillance in vaccine decision-making: A series of case studies in Bangladesh, Armenia and the Gambia.
Hasan AZ; Saha S; Saha SK; Sahakyan G; Grigoryan S; Mwenda JM; Antonio M; Knoll MD; Serhan F; Cohen AL;
Vaccine; 2018 Aug; 36(32 Pt B):4939-4943. PubMed ID: 30037484
[TBL] [Abstract][Full Text] [Related]
5. Cocontribution of Rotavirus and Pneumococcal Conjugate Vaccines to the Reduction of Pediatric Hospital Visits in Young Children.
Ben-Shimol S; Givon-Lavi N; Greenberg D; Dagan R
J Pediatr; 2017 Mar; 182():253-259.e2. PubMed ID: 27939127
[TBL] [Abstract][Full Text] [Related]
6. Effect of the introduction of pneumococcal conjugate vaccination on invasive pneumococcal disease in The Gambia: a population-based surveillance study.
Mackenzie GA; Hill PC; Jeffries DJ; Hossain I; Uchendu U; Ameh D; Ndiaye M; Adeyemi O; Pathirana J; Olatunji Y; Abatan B; Muhammad BS; Fombah AE; Saha D; Plumb I; Akano A; Ebruke B; Ideh RC; Kuti B; Githua P; Olutunde E; Ofordile O; Green E; Usuf E; Badji H; Ikumapayi UNA; Manjang A; Salaudeen R; Nsekpong ED; Jarju S; Antonio M; Sambou S; Ceesay L; Lowe-Jallow Y; Jasseh M; Mulholland K; Knoll M; Levine OS; Howie SR; Adegbola RA; Greenwood BM; Corrah T
Lancet Infect Dis; 2016 Jun; 16(6):703-711. PubMed ID: 26897105
[TBL] [Abstract][Full Text] [Related]
7. Estimated public health impact of human rotavirus vaccine (HRV) and pneumococcal polysaccharide protein D-conjugate vaccine (PHiD-CV) on child morbidity and mortality in Gavi-supported countries.
Marijam A; Schuerman L; Izurieta P; Pereira P; Van Oorschot D; Mehta S; Ota MO; Standaert B
Hum Vaccin Immunother; 2022 Dec; 18(7):2135916. PubMed ID: 36507685
[TBL] [Abstract][Full Text] [Related]
8. Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.
Constenla D; Liu T
Vaccine; 2019 Dec; 37(52):7547-7559. PubMed ID: 31607600
[TBL] [Abstract][Full Text] [Related]
9. Projected health benefits and costs of pneumococcal and rotavirus vaccination in Uganda.
Tate JE; Kisakye A; Mugyenyi P; Kizza D; Odiit A; Braka F
Vaccine; 2011 Apr; 29(17):3329-34. PubMed ID: 21241733
[TBL] [Abstract][Full Text] [Related]
10. Global invasive bacterial vaccine-preventable diseases surveillance--2008-2014.
Murray J; Agócs M; Serhan F; Singh S; Deloria-Knoll M; O'Brien K; Mwenda JM; Mihigo R; Oliveira L; Teleb N; Ahmed H; Wasley A; Videbaek D; Wijesinghe P; Thapa AB; Fox K; Paladin FJ; Hajjeh R; Schwartz S; Van Beneden C; Hyde T; Broome C; Cherian T;
MMWR Morb Mortal Wkly Rep; 2014 Dec; 63(49):1159-62. PubMed ID: 25503919
[TBL] [Abstract][Full Text] [Related]
11. The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
Agudelo CI; Castañeda-Orjuela C; Brandileone MCC; Echániz-Aviles G; Almeida SCG; Carnalla-Barajas MN; Regueira M; Fossati S; Alarcón P; Araya P; Duarte C; Sánchez J; Novas M; Toraño-Peraza G; Rodríguez-Ortega M; Chamorro-Cortesi G; Kawabata A; García-Gabarrot G; Camou T; Spadola E; Payares D; Andrade AL; Di Fabio JL; Castañeda E;
Lancet Infect Dis; 2021 Mar; 21(3):405-417. PubMed ID: 32986996
[TBL] [Abstract][Full Text] [Related]
12. Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.
Jayasinghe S; Menzies R; Chiu C; Toms C; Blyth CC; Krause V; McIntyre P
Clin Infect Dis; 2017 Jan; 64(2):175-183. PubMed ID: 27986682
[TBL] [Abstract][Full Text] [Related]
13. The preventable burden of pneumococcal disease in the developing world.
Scott JA
Vaccine; 2007 Mar; 25(13):2398-405. PubMed ID: 17028081
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: South Africa, 2003-2008.
von Gottberg A; Cohen C; de Gouveia L; Meiring S; Quan V; Whitelaw A; Crowther-Gibson P; Madhi SA; Whitney CG; Klugman KP
Vaccine; 2013 Aug; 31(38):4200-8. PubMed ID: 23684826
[TBL] [Abstract][Full Text] [Related]
15. Methods and challenges in measuring the impact of national pneumococcal and rotavirus vaccine introduction on morbidity and mortality in Malawi.
Bar-Zeev N; Kapanda L; King C; Beard J; Phiri T; Mvula H; Crampin AC; Mwansambo C; Costello A; Parashar U; Tate JE; Verani JR; Whitney CG; Heyderman RS; Cunliffe NA; French N;
Vaccine; 2015 May; 33(23):2637-45. PubMed ID: 25917672
[TBL] [Abstract][Full Text] [Related]
16. The composition of demand for newly launched vaccines: results from the pneumococcal and rotavirus vaccine introductions in Ethiopia and Malawi.
Williams BA; Kidane T; Chirwa G; Tesfaye N; Prescott MR; Scotney ST; Valle M; Abebe S; Tambuli A; Malewezi B; Mohammed T; Kobayashi E; Wootton E; Wong R; Dosani R; Subramaniam H; Joseph J; Yavuz E; Apple A; Le Tallec Y; Kang'ethe A
Health Policy Plan; 2016 Jun; 31(5):563-72. PubMed ID: 26856361
[TBL] [Abstract][Full Text] [Related]
17. Rota and pneumococcus vaccine success stories: pediatric emergency practitioners wonder "where have the kids gone?".
McKenna M
Ann Emerg Med; 2009 Apr; 53(4):23A-25A. PubMed ID: 19320052
[No Abstract] [Full Text] [Related]
18. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
Tohme RA; Francois J; Cavallaro KF; Paluku G; Yalcouye I; Jackson E; Wright T; Adrien P; Katz MA; Hyde TB; Faye P; Kimanuka F; Dietz V; Vertefeuille J; Lowrance D; Dahl B; Patel R
Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):28-36. PubMed ID: 29064356
[TBL] [Abstract][Full Text] [Related]
19. Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands.
Knol MJ; Wagenvoort GH; Sanders EA; Elberse K; Vlaminckx BJ; de Melker HE; van der Ende A
Emerg Infect Dis; 2015 Nov; 21(11):2040-4. PubMed ID: 26488415
[TBL] [Abstract][Full Text] [Related]
20. South Asia symposium on pneumococcal disease and the promise of vaccines - Meeting report.
Kumar R; Arora N; Santosham M
Vaccine; 2016 May; 34(23):2622-6. PubMed ID: 27026150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
